<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
DECEMBER 19, 2000
-----------------------------------
(Date of earliest event reported)
PRAECIS PHARMACEUTICALS INCORPORATED
-----------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 000-30289 04-3200305
------------------------------- --------------------- -------------------
(State or other Jurisdiction of (Commission File No.) (IRS Employer
Incorporation) Identification No.)
ONE HAMPSHIRE STREET, CAMBRIDGE, MASSACHUSETTS 02139-1572
------------------------------------------------------------
(Address of principal executive offices, including zip code)
(617) 494-8400
-----------------------------------------------------
(Registrant's telephone number, including area code)
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events.
PRAECIS PHARMACEUTICALS INCORPORATED's press release dated
December 19, 2000 is incorporated herein by reference and is attached hereto as
Exhibit 99.1.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits:
99.1 Press Release by PRAECIS PHARMACEUTICALS INCORPORATED dated
December 19, 2000.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: December 19, 2000 PRAECIS PHARMACEUTICALS INCORPORATED
By /s/ Kevin F. McLaughlin
--------------------------------------
Kevin F. McLaughlin
Senior Vice President, Chief Financial
Officer, Treasurer and Secretary
3
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description
99.1 Press Release by PRAECIS PHARMACEUTICALS INCORPORATED dated
December 19, 2000.
